2014 AANS Annual Report - page 34

34
2014
ANNUAL REPORT
NeuroPoint Alliance (NPA) was established in 2008 by the American
Association of Neurological Surgeons to collect, analyze and report on
nationwide clinical data from neurosurgical practices. It is supported
by other neurological societies, including the Congress of Neurological
Surgeons (CNS), Society of Neurological Surgeons (SNS) and the
American Board of Neurological Surgery (ABNS). NPA is a not-for-
profit 501(c)(6) corporation that coordinates a variety of national and
international projects.
NPA is designed to meet the quality care and research needs of a broad
range of health-care stakeholders, including individual practitioners,
practice groups, national professional organizations, health-care plans
and the biomedical industry. Industry-sponsored studies can include
randomized trials, registries and post-marketing surveillance of new
devices. NPA’s capabilities include outcomes research, universal
data reporting requirements for maintenance of certification (MOC),
maintenance of licensure (MOL) and the physician quality reporting
system (PQRS) and local and national quality improvement efforts.
NPA, partnering with Outcome/Quintiles, serves as the data collection
agency for the ABNS candidate case logs and Maintenance of Certification
(MOC) part 4 key case reporting requirements. NPA continues working
with the ABNS regarding refinements to its existing MOC program.
The NPA’s most significant initiative in fiscal year 2014 continued to be
the National Neurosurgery Quality and Outcomes Database (N
2
QOD), a
prospective clinical registry designed to address the need for high-quality
patient outcomes data related to care of patients with neurosurgical
disorders. The N
2
QOD tracks, analyzes and reports on the quality of
surgical care for the most common neurosurgical procedures. It is the
first and currently only nationally coordinated registry in the United States
to measure one-year effectiveness of care using validated patient centered measures. NPA works with
the Vanderbilt Institute for Medicine and Public Health (VIMPH) to manage the collection and analysis
of N
2
QOD data. In 2013, VIMPH began providing descriptive benchmarks and risk-adjusted variables in
N
2
QOD reports to participating centers.
NEUROPOINT ALLIANCE:
ADVANCING PATIENT CARE THROUGH
THE SCIENCE OF PRACTICE
1...,24,25,26,27,28,29,30,31,32,33 35,36,37,38,39,40,41,42,43,44,...48
Powered by FlippingBook